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The chloride intracellular channel (CLIC) family of proteins has the remarkable property of maintaining both a soluble form and
an integral membrane form acting as an ion channel. The soluble form is structurally related to the glutathione-S-transferase
family, and CLIC can covalently bind glutathione via an active site cysteine. We report approximately 0.6 𝜇s of molecular dynamics
simulations, encompassing the three possible ligand-bound states of CLIC1, using the structure of GSH-bound human CLIC1.
Noncovalently bound GSH was rapidly released from the protein, whereas the covalently ligand-bound protein remained close to
the starting structure over 0.25 𝜇s of simulation. In the unliganded state, conformational changes in the vicinity of the glutathione-
binding site resulted in reduced reactivity of the active site thiol. Elastic network analysis indicated that the changes in the
unliganded state are intrinsic to the protein architecture and likely represent functional transitions. Overall, our results are
consistent with a model of CLIC function in which covalent binding of glutathione does not occur spontaneously but requires
interaction with another protein to stabilise the GSH binding site and/or transfer of the ligand. The results do not indicate how
CLIC1 undergoes a radical conformational change to form a transmembrane chloride channel but further elucidate the mechanism
by which CLICs are redox controlled.
1. Introduction
The chloride intracellular channel (CLIC) family of proteins
consists of six distinct members in vertebrates: CLIC1-6.
Most CLICs are localized to intracellular membranes and are
known to participate in protein-protein interactions, particu-
larly with cytoskeletal components [1–5]. The oxidation state
of CLIC has been found to affect the activity of associated
chloride channels, and CLICs have been shown in vitro to
insert from the aqueous phase into phospholipidmembranes,
where they can function as an anion channel [6, 7]. CLIC
proteins can also act as substrates of various kinases [8], and,
as has been shown for CLIC5B, tyrosine phosphorylation
may affect activity [9, 10]. Although these proteins have been
linked to functions including apoptosis and pH and cell cycle
regulation [11–13], their exact role in normal cell physiology
is uncertain.
The CLIC family is defined by a C-terminal core segment
of approximately 230 amino acids that is highly conserved
among all family members. Sequences upstream this core
vary considerably among the various family members in
length and sequence. CLIC1 has been most intensely studied
[6, 14–17] and has only a few amino acids upstream of the
conserved core that defines the CLIC family. CLIC1 has
been shown to assume both soluble and integral membrane
forms, which presumably differ radically in conformation.
The crystal structure of a soluble monomeric form of CLIC1
was found to be a structural homologue of the glutathione-S-
Transferase (GST) superfamily of proteins [6]. This soluble
form of CLIC1 consists of two domains: the N-domain
possessing a thioredoxin fold closely resembling glutaredoxin
and an all 𝛼-helical C-domain, which is typical of the GST
superfamily (Figure 1). CLIC1 contains an intact glutathione-
binding site that was shown to covalently bind glutathione
(GSH) via a conserved CLIC cysteine residue, Cys24.This led
to the suggestion that CLICs are likely to be GSH-dependent
redox-active proteins. The structure of the soluble form of
CLIC1 indicates that it closely resembles that of the Omega

























Figure 1: Structure and dynamics of human CLIC1. (a) Ribbon rep-
resentation of the human CLIC1 structure used in the simulations.
GSH is shown in stick form. The foot loop (residues 147–164) was
modeled using coordinates from nonliganded CLIC1 (PDB 1K0M).
Secondary structural elements discussed in the text are as indicated.
Residues are shaded according to the combined fluctuations for slow
modes 1–5 from the GNM analysis with white, low and black, high
fluctuations. (b) Per residue plot of average of RMS fluctuations
of C𝛼 atoms from all simulations (black). The fluctuation profile
predicted by GNM analysis for slow modes 1–5 is in grey. The GNM
data are scaled linearly to fit the range of the MD data for the
purposes of comparison.
class GST [18]. The Omega class GST GSTO1-1 modulates
ryanodine receptors, which are the calcium release channels
in skeletal and cardiac sarcoplasmic reticulum [19].
In order to investigate the role andmolecular mechanism
of CLIC1, we performed molecular dynamics (MD) simula-
tions of the three possible ligand-bound states of the mole-
cule: no ligand (apo); GSH noncovalently bound; and GSH
covalently bound. The simulations revealed that CLIC1
undergoes distinct structural changes in each of the different
states that, together with experimental data, support a model
for CLIC function in which GSH is transferred to the protein
by an unknown enzyme.
2. Experimental Procedures
The crystal structure of soluble monomeric GSH-bound
CLIC1 (PDB 1K0N, monomer A) was used as the starting
structure for all simulations. Residues 153 to 162 are disor-
dered in this structure and the coordinates for this region
were generated using the apo structure (PDB 1K0M). The
GSH-boundCLIC structure (1K0N)was determined by soak-
ing crystals fromwhich the apo structure (1K0M)was derived
with oxidised glutathione; glutathione binding induced only
small changes in the protein structure (RSMD of 0.29 A˚
between monomer A in apo and glutathione bound). Engi-
neered mutation Glu151Gly was reversed. Molecular Dynam-
ics (MD) simulations were performed using the paral-
lel MD program NAMD 2.6 [20] with the CHARMM27
force field [21] including 𝜑/𝜓 cross-term map corrections
[22] and the TIP3P model for water [23]. Parameters for
GSH were derived from CHARMM protein parameters
as described (http://www.ks.uiuc.edu/Research/namd/). The
SHAKE algorithm was used to constrain the bonds contain-
ing hydrogens to their equilibrium length [24]. A cutoff of
12 A˚ (switching function starting at 10 A˚) for van der Waals
interactions and real space electrostatic interactions was
used. Periodic boundary conditions were used andminimum
distances between periodic images of the protein were 20 A˚
in all cases. The particle-mesh Ewald method [25] was used
to compute long-range electrostatic forces with a grid density
of approximately 1/A˚3. An integration time step of 1.5 fs was
used, permitting a multiple time-stepping algorithm to be
employed inwhich interactions involving covalent bonds and
short-range nonbonded interactions were computed every
time step, whereas long-range electrostatic forces were com-
puted every two time steps. Langevin dynamics were utilized
to keep a constant temperature of 310 K in all simulations
with a friction coefficient of 5 ps−1 on all nonhydrogen atoms.
Constant pressure simulations at 1 atm were conducted using
a Langevin piston method with a decay period of 100 fs and a
damping timescale of 50 fs. An initial set of three simulations
was performed with a 0.2M NaCl solution and a second set
of three equivalent simulations used minimum sodium ions
to electrically neutralise the system.
The solvated starting structure was minimized using
conjugate gradient minimization to a 0.5 kcal/mol⋅A˚ RMS
gradient with all protein heavy atoms fixed. Water molecules
and protein hydrogens were then further minimized during
a 50 ps molecular dynamics run at 310 K, in which all protein
heavy atoms were again fixed. This starting model was
then minimized with harmonic positional constraints on the
NC𝛼CO backbone. A 100 kcal/mol⋅A˚2 force constant was
used to minimise the system to a 0.5 kcal/mol⋅A˚ RMS gra-
dient.The constraints were gradually removed by subsequent
minimizations to a 0.1 kcal/mol⋅A˚ rms gradient, scaling the
initial force constants by factors of 0.5, 0.15, 0.05, and 0. The
minimized structure was then heated from 50K to 310K in
steps of 25K using velocity reassignment during a 30 ps MD
run. This equilibrated structure was used for the production
run in which no restraints were applied.
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Using the 1K0N monomer A structure, three simulations
of the possible ligand bound states of the molecule were
performed: (i) no ligand (apo1, 95M steps = 142.5 ns); (ii)
GSH covalently bound (cov1, 75M steps = 112.5 ns); (iii)
GSH noncovalently bound (ncv1, 48.7M steps = 73 ns). A
second set of simulations was performed in which the C-
terminal residues 234–241 were modeled in an 𝛼-helical
structure, such that these residues extended the C-terminal
𝛼-helix (residues 226–233). Coordinates for residues 234–241
were generated by structurally aligning a regular 𝛼-helix of
suitable length with the C𝛼 atoms of residues 226–233 and
then generating the side chains of residues 234–241 using the
mutate function in Swiss-PdbViewer [26]. Using this starting
structure, three simulations of the possible ligand bound
states of the molecule were performed: (i) no ligand (apo2,
75M steps = 112.5 ns); (ii) GSH covalently bound (cov2, 95M
steps = 142.5 ns); (iii) GSHnoncovalently bound (ncv2, 10 ns).
In addition, a third simulation with GSH noncovalently
bound, using the crystal structure of human CLIC1 with
the Q63E mutation reversed, was also performed (ncv3,
23 ns). The noncovalently ligand-bound simulations were
terminated following release of the ligand. All simulations
remained stable to completion. Coordinates were saved every
1000 integration steps (1.5 ps).
Principal component analysis (PCA) of the C𝛼 atom
coordinate trajectory was used to identify and characterise
global conformational transitions. PCA defines a set of eigen-
vectors (EVs) derived from the matrix of pairwise correlated
motion of atoms. EVs are ranked according to the amplitude
of the protein motions they describe, and in general, the first
1 to 4 EVs account for the most concerted 50% or more of
protein fluctuations. PCA of the simulation 𝛼-carbon atom
trajectories was performed using the GROMACS package
[27]. N-terminal residues 1–5 and foot loop residues 145–165
were not included in the PCA analysis. Trajectory frames
were first aligned to the starting structure using coordinates
of the structural core (residues 25–37, 76–88, 93–98, 139–143,
167–186, and 205–215). Fluctuations were referenced to the
average structure of the trajectory. Secondary structure of
simulation trajectory frames was analysed using the method
of Kabsch and Sander [28] as implemented in Simulaid
(http://atlas.physbio.mssm.edu/∼mezei/).
Calculation of the pKa of residue Cys24 was performed
with the MCCE package [29, 30] using the single conformer
protocol supplied with the program. Elastic network analyses
were performed on the CLIC1 structure using the online
facility [31] available at http://ignm.ccbb.pitt.edu/, using
default settings. Calculation of electrostatic potential was
performed using Delphi v4 [32]; electrostatic potential is
expressed in units of kT/e (𝑘 = 0.001986577 kcal/mol⋅K).
Sequence variability of CLICs, expressed as the Shannon
entropy [33, 34], was calculated using the online Sequence
Variability Server available at http://bio.dfci.harvard.edu/
Tools/sva.html. A CLUSTALW alignment of the closest 100
sequences to human CLIC1, as determined from a BLAST
search of the Swiss-Prot database, was used as input to the
Sequence Variability Server. The variability in each column
of the multiple sequence alignment is calculated using the
Shannon entropy (𝐻) function. All structural figures were
prepared using VMD [35, 36], (available at http://www.ks
.uiuc.edu/Research/vmd/) except for Figures 3(b), 3(c), and
Figure 5(a), which were prepared using PyMol [37].
3. Results
In this study, we performed MD simulations of the three
possible ligand-bound states of human CLIC1: (i) no ligand
(apo); (ii) GSH noncovalently bound (ncv); and (iii) GSH
covalently bound (cov). Two sets of simulations of these three
states were performed: the first set using the crystal structure
of human CLIC1 as the starting structure and the second set
using the same structure, but with the C-terminal residues
234–241 modeled in an 𝛼-helical conformation (see below).
In addition, a third simulation with GSH noncovalently
bound, using the crystal structure of human CLIC1 with
ligand-binding residue Glu63 changed to a glutamine, was
also performed. The combined total of real-time simulated
was approximately 0.6 𝜇s.
As a point of comparison for the MD analysis, Elastic
Network (EN) analysis of the CLIC1 structure was also
performed.TheENapproach is a normalmode analysis based
on a coarse-grained model in which the protein is modeled
as a set of points, corresponding to the C𝛼 atom positions,
connected to their nearest neighbours by simple harmonic
springs [38]. This analysis can identify the principal corre-
lated motions in proteins, which play a predominant role in
effectuating functional motions. These are usually described
within the 5 slowest modes [39], although not all EN modes
necessarily represent functional motions. Based solely on the
protein contact topology, EN analysis provides an indepen-
dent methodology with which one can compare the results
of the MD studies and can also provide insights into con-
formational transitions that occur on timescales beyond the
reach of the atomistic simulations. Here, we employ both the
Gaussian Network Model [40] and the Anisotropic Network
Model (ANM; [41]) and discuss ENmodes that correlate with
the results ofMD simulations.We also employ principal com-
ponent analysis (PCA; seeMethods) to analyse the simulation
trajectories. PCA filters the most concerted global protein
changes from random fluctuations and can be used to delin-
eate and characterise motions linked to biological function.
3.1. MD and GNM Identify Dynamic Regions of the CLIC1
Structure. Figure 1(b) shows plots of the average-per-residue
fluctuations from all theMD simulations and for comparison,
the combined fluctuations from slow modes 1–5 from the
GNM analysis. To give a structural reference, the CLIC1
structure in Figure 1(a) is shaded according to the value
of the GNM data plotted. In general, the GNM and MD
analyses are in agreement regarding the regions of the
protein that undergo elevated fluctuations. In particular, the
“foot loop” region (residues 146–165) is notable for its high
mobility, consistent with its disordered nature in the crystal
structure.The other regions with high fluctuations in theMD
simulations are 𝛼-helix 2 and the loops at its N and C termini
(residues 48–63) and the region of the loop joining 𝛼-helices
4b and 5. Perhaps the most notable difference between the
two analyses is that GNM predicts high fluctuations for the
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Figure 2: Time course of conformational changes in the apo and covalently ligand-bound simulations. Data from the apo1 simulation are in
the left panels and those from the cov1 simulation are in the right panels. All measurements were taken at 150 ps intervals. (a) RMS deviation
of C𝛼 atoms from the starting structure (not including residues 1–5 or 146–165). (b) Projection of PCA EV1 from the C𝛼 trajectory (not
including residues 145–165). (c) Backbone 𝜑 dihedral angle of residue Asn23. (d) Backbone 𝜓 dihedral angles of residues 194 (blue), 195 (red),
197 (black), and 198 (green). (e) Distance between the hydroxyl oxygen of Tyr233 and the sulfur atom of Cys24 (green) and moving average
over 20 150 ps intervals of distance between the hydroxyl oxygen of Tyr233 and the side chain 𝛽-carbon atom of Cys24 (red).



















Figure 3: Conformational changes around the GSH-binding site in the apo1 simulation. (a) Global structural changes. Stereo pair in cartoon
representation of the superimposed trajectory frames corresponding to the maximum (yellow, 𝑡 = 7.6 ns) andminimum (green, 𝑡 = 129.4 ns)
projection structures for EV1 from the apo1 simulation. The view is similar to that in Figure 1. Tyr233 and Cys24 from the maximum
projection structure are depicted in ball and stick and coloured red. Secondary structural elements discussed in the text are as indicated.
(b)-(c) Interaction of Tyr233 and Cys24. Residues shown in stick form with carbon coloured cyan, oxygen red, nitrogen blue, and sulphur















Figure 4: Correspondence between MD and GNM analysis of protein dynamics. Per residue plot of RMS fluctuations of C𝛼 atoms derived
from PCA of apo simulation 1 (EV1) are in black. Foot loop residues 145–165 were not included in the PCA analysis. The fluctuation profile
predicted byGNManalysis for slowmode 5 is in grey.TheGNMdata are scaled to fit the range of theMDdata for the purposes of comparison.
loop at the C-terminus of 𝛼-helix 3 (residues 89–94, loop
at top centre right in Figure 1(a)), in agreement with high
temperature factors for this region in the crystal structure,
although in general, only moderately elevated fluctuations
were observed for this region in the MD simulations. We
note that in the 1.4 A˚ crystal structure of apo CLIC1, there are
two monomers in the asymmetric unit with Pro91 adopting a
cis conformer in monomer A, whereas Pro91 in monomer B
appears to be in both cis and trans conformations [6].
3.2. Conformational Changes in the Apo State. Two initial
simulations of 75M time-steps (112.5 ns) of the apo (apo1)


















































Figure 5: Binding of GSH and mechanism of release from the noncovalently bound state. (a) Interactions of GSH with CLIC1. Final frame
from the cov1 simulation (𝑡 = 112.5 ns). GSH and protein regions which interact with the ligand are shown in stick representation with
nitrogen blue, oxygen red, and sulphur orange; carbon atoms of GSH are green and those of CLIC1 are tan. Residues and ligand are as labeled.
Interactions discussed in the text are indicated by dotted lines and coloured as in Supplementary Figure 6 (Supplementary Material available
at http://dx.doi.org/10.1155/2013/170586). (b) EV2 and (c) EV3 from PCA of the combined apo1 and cov1 simulations. Stereo image of the C𝛼
trace of the superimposed maximum (green) and minimum (red) projection structures. The view is roughly orthogonal to that in Figure 1,
equivalent to the perspective from the bottom of the page in Figure 1, along the axis of 𝛼-helix 1; the N-terminal subdomain is on the right
and the C-terminal subdomain on the left. (d) Concerted motions in the ncv2 and ncv3 simulations show a peak in the most concerted 50%
of C𝛼 atom fluctuations for residues 60–63. Per residue fluctuations due to EVs 1–5 from PCA analysis of the C𝛼 trajectory of simulation ncv2
(black) and EVs 1–4 from simulation ncv3 (grey). Residues 145–165 were not included in the PCA analysis.
and covalently bound ligand state (cov1) were performed.The
apo1 simulation was continued for a further 20M timesteps
(to 142.5 ns), as discussed below. Figure 2 shows results from
the apo1 and cov1 simulations, which illustrate and charac-
terise differences between them.A significant conformational
change occurred in the apo state that did not occur in the
covalently bound ligand state, the latter remaining closer
to the starting structure throughout the simulation. This is
illustrated in Figure 2(a), which show the time course of the
rms deviation of the C𝛼 coordinates relative to the starting
structure. Figure 2(b) shows the time course of the projection
of PCA EV1, which characterises the most concerted global
changes in the protein. This measure also shows clearly
that for the apo1 simulation EV1 describes an equilibration
to a significantly different conformation from the starting
structure, whilst in contrast concerted global change in the
ligand-bound protein is not as marked.
The large conformational change in the apo simulation
involved concerted alterations in several areas of the protein.
Themost notable of these involved an alteration in the orien-
tation of the C-terminal 𝛼-helix 9 (residues 226–233), which
pivoted about its N-terminus. In addition, the C-terminal tail
formed 𝛼-helical structure, extending 𝛼-helix 9 (Figure 3(a)),
resulting in an 𝛼-helix between residues 226–240; this 𝛼-
helix formed a hydrophobic face oriented toward the GSH
binding site. The loop region joining 𝛼-helices 6 and 7
(residues 195–198) adopted a more compact conformation by
way of alterations in backbone dihedral angles (Figure 2(d)).
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This allowed the C-terminus of 𝛼-helix 6 to move away from
the active site, thereby in turn facilitating the alterations in
the orientation of the C-terminal helix (Figure 3(a)).
The conformational changes in the apo simulation
resulted in the direct interaction between the hydroxyl group
of Tyr233 and the conserved active site Cys24 (Figures 2, 3(b),
and 3(c)). The interaction between Tyr233 and Cys24 was
also facilitated by an alteration in the conformation of residue
Asn23 at the N-terminus of 𝛼-helix 1 (Figure 2(c)), such that
its side chain moved away from the open cavity around the
active site, enabling the side chain of Cys24 to point toward
Tyr233 (Figure 3(c)). At the end of the initial apo simulation
(𝑡 = 112.5 ns), the distance between Tyr233 and Cys24 was
increasing, and so another 20M steps of simulation were per-
formed to ensure that the structure was indeed equilibrating
toward a stable interaction of Tyr233 and Cys24 (Figure 2).
The conformational changes in the C-terminal 𝛼-helix 9
in the apo simulation, that resulted in the direct interaction of
Tyr233 and Cys24, appeared connected to the disengagement
of the C-terminal tail (residues 237–241) from a number of
electrostatic and hydrophobic contacts with residues vicinal
to the C-terminus of 𝛼-helix 6 (Figure 3(a)). Although this
change from the crystal structure did not occur in the
covalently ligand-bound simulation, it appeared possible that
had the C-terminal tail similarly disengaged, the confor-
mational changes observed in the apo simulation might
also have occurred in the covalently ligand-bound CLIC.
In other words, because of the stochastic nature of protein
dynamic processes, it is possible that the covalently ligand-
bound simulation did not have sufficient time to undergo the
conformational change observed in the apo state.
In order to find further evidence that the observed
differences between the apo and covalently ligand bound
simulations were due to their ligand-bound state, a second
set of simulations of 75M timesteps was performed in which
C-terminal residues 226–241 were modeled as a continuous
𝛼-helix in the starting structure. As a further test of the
robustness of the results, the second set of simulations
used only the minimum counterions required to electrically
neutralise the system rather than a 0.2M electrolyte solution.
As illustrated in Supplementary Figure 1(a), the interaction
of Tyr233 and Cys24 and the concomitant protein confor-
mational changes observed in the initial apo simulation were
essentially repeated in the second apo simulation, however, as
in the first simulations, did not occur in the second covalently
ligand-bound simulation. The cov2 simulation was extended
for another 20M time steps to ensure that it had equilibrated.
Notably, in the apo2 simulation, the initial 𝛼-helical structure
imposed on the C-terminal residues was disrupted during the
early part of the simulation, but reformed consistently in the
second half of the simulation (Supplementary Figure 1(b)).
Gaussian network model (GNM) analysis of the CLIC1
structure provides additional support for the idea that the
conformational changes observed in the apo simulations de-
scribe functional transitions intrinsic to the protein. Figure 4
illustrates how residues involved in motions described by
slow mode 5 from the GNM analysis generally correspond
with those derived from the PCA describing conformational
changes in the apo1 simulation (EV1), as discussed above.
Although the correspondence is not exact with respect to the
regions involved in the transitions, it is notable that GNM
EV5 describes correlated motions (same direction) of the C-
terminal 𝛼-helix 9 and 𝛼-helix 7, anticorrelated with motions
of the region of the N-terminal of 𝛼-helix 5 and 𝛼-helix 2, on
the opposite side of the mouth around the active site (Supple-
mentary Figure 2).This is similar to the transition that occurs
during the equilibration in the apo simulations (Figure 3(a)).
Supplementary Figure 3 further illustrates how the first 1–5
GNM modes contribute dominantly to the most concerted
fluctuations observed in the apo1 and cov1 simulations.
3.3. Conformational Changes in the Unliganded State Result
in Reduced Reactivity of the Active Site Thiol. We examined
the effect of the change in proximity of Tyr233 and Cys24 on
the pKa of Cys24 using continuum electrostatic calculations.
The pKa of Cys24 was calculated in the 10 ns equilibrated
structure and the final structure (𝑡 = 142.5 ns) from the
apo1 simulation. The calculated pKa of Cys24 in the 10 ns
equilibrated structure was 7.0 and in the final structure 8.54.
This indicates that the pKa of Cys24 is shifted significantly
toward neutrality in both structures, consistent with its role
in forming a disulphide bond with GSH [42]. It also indicates
that the active site thiol will more readily lose its proton in the
10 ns equilibrated structure than the final structure, following
the global conformational change described above.
The breakdown of the calculated energy terms that
contributes to the pKa of Cys24 indicated that the loss of
interactions of the Cys24 side chain with the peptide back-
bone and with Ser27, in the latter part of the apo simulation
(Figure 3(c)), accounts for the change in pKa between the
10 ns equilibrated structure and the final structure (𝑡 =
142.5 ns) from apo simulation 1 (Supplementary Table 1).This
in turn is due to the conformational changes in both the
peptide backbone of residues 23-24 and the sidechain rotamer
of Cys24, which occur during the apo simulation (Figures 2,
3(b), and 3(c)). It is notable that the disposition of the Cys24
side chain in the 10 ns equilibrated apo structure is essentially
the same, with respect to atoms of Ser27 and the electrostatic
dipole of 𝛼-helix 1, as observed in the GSH-bound crystal
structure. Thus, the data suggest that the Cys24 thiol would
be less reactive in the conformation observed in the final
apo structure, where it interacts with Tyr233, than in the
conformation it is in when GSH is covalently bound.
Thedata also highlight the likely role of Ser27 in activating
the active site thiol. In addition to these changes in the vicinity
of the active site, it is notable that in both apo simulations,
Phe26, which is part of the conserved Cys-Pro-(Phe/Tyr)-
(Cys/Ser) GSH-binding motif found in the glutaredoxins
[43], rotates into the area occupied by the ligand when it is
covalently bound. This occurs transiently in the latter half of
the apo simulation 2 but occurs in a more sustained manner
in apo simulation 1 (Supplementary Figure 4).
Finally, the CLIC1 sequence was analysed for possible
phosphorylation sites by the NetPhos 2.0 and NetPhosK
servers. The NetPhos 2.0 server produces neural network
predictions for serine, threonine, and tyrosine phosphoryla-
tion sites in eukaryotic proteins [44]. This analysis predicted
that Tyr233 in CLIC1 has a phosphorylation potential of
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approximately 95% (Supplementary Figure 5).TheNetPhosK
analysis [45] detects kinase-specific phosphorylation sites
and predicts Tyr233 to be a potential SRC kinase phospho-
rylation site with a moderate score of 53%. This result may
have significance in view of the conservation of Tyr233 in
the CLIC fold, together with experimental observations that
some CLICs interact with kinases and that CLIC5B interacts
with c-src kinase [9].
3.4. Binding of Glutathione. The CLIC N-domain has a well-
conserved glutaredoxin-like GSH binding site and in the
crystal structure GSH is covalently attached to Cys24 via
a disulfide bond to the conserved active site cysteine. The
CLIC1 binding site has fewer interactions between GSH and
the protein than observed in GSTs, with no interactions with
either the terminal nitrogen of the 𝛾-glutamyl moiety or the
cystyl carbonyl group, which are present in all structures
of GST-GSH complexes. However, in both of the present
simulations of the covalently GSH-bound CLIC1, protein-
ligand interactions analogous to those observed in GSTs are
formed. Thus, the terminal nitrogen of the GSH 𝛾-glutamyl
moiety forms hydrogen bonds with the side chains of Asp76
and Glu63 (Figure 5(a)). These interactions are analogous to
those observed in GSTs in that Asp76 and Glu63 are situated
in equivalent positions in the shared conserved fold to an
aspartate and glutamine residue, respectively, in GSTs.
It should be noted that the crystallised protein (1K0N)
contains a glutamate at position 63, whereas the Swiss-Prot
database entry for human CLIC1 (Accession no. O00299)
contains a glutamine. This difference is due to a sequence
error in the original CLIC1 clones resulting in Glu63.
Although the residue at this position varies among CLICs, it
is nearly always glutamine, asparagine, or histidine. Nonethe-
less, the simulations show that a glutamate side chain is able
to form a stable salt bridge (Supplementary Figure 6) with
the terminal nitrogen of the GSH 𝛾-glutamyl moiety of the
ligand, thus performing a similar function to the canonical
residue at this position in GSTs. We have solved the crystal
structure of the truewild-type sequencewithGln63 (Phang et
al., unpublished results). The structure is essentially identical
to the Glu63 mutant structure.
In addition to the interactions of Asp76 and Glu63 with
the ligand, hydrogen bonds between the backbone amide
of the GSH cystyl moiety and the carbonyl of Leu64, and
between the carboxyl group of the 𝛾-glutamyl moiety and
the side chain of Thr77 (Figure 5(a)), observed in the crystal
structure, remain stable throughout both covalently ligand-
bound simulations (Supplementary Figure 6).TheGSHcystyl
carbonyl group interacts with the backbone amide of Leu64,
also in a manner analogous to that observed in GSTs,
although the interaction is more volatile than those involving
the terminal nitrogen of the GSH 𝛾-glutamyl moiety. In
addition, a hydrogen bond forms intermittently between the
carboxyl of the 𝛾-glutamylmoiety and the backbone amide of
Thr77. Notably, conserved Arg29, which corresponds to the
conserved Lys/Arg in glutaredoxins [43] does not bind to the
ligand as occurs inGSTs, consistentwith distinctmechanisms
with respect to their active sites between the two classes of
proteins [19].
3.5. RelativeMotions of theN- andC-terminal SubdomainsAre
Correlated with the Ligand-Bound State. In order to compare
the apo and covalently ligand-bound states, we performed
PCA analysis on the combined trajectories of simulations
apo1 and cov1, using the initial 75M timesteps from each
trajectory. PCA mode 1 from this analysis was essentially
identical to principalmode 1 fromPCAof the apo1 simulation
alone, discussed above (subspace overlap >94%). The same
result was also found when PCA of all trajectories combined
was performed (subspace overlap >91%). This indicates that
this mode describes the largest amplitude global motion that
occurred in any of the simulations.
Modes 2 and 3 from PCA analysis of the combined tra-
jectories of simulations apo1 and cov1 described two distinct
motions, each involving a characteristic relative movement
between the N- and C-terminal subdomains of the protein
(Figures 5(b) and 5(c)). The first of these involved a global
twisting along the long axis of the protein, which runs roughly
along the groove between the N- and C-terminal domains.
In the second motion, an opening and closing of the cleft
that divides the N- and C-terminal domains occurs resulting
in a breathing motion around the mouth of the active site.
Supporting the idea that these motionsmay have a functional
role, principal modes 1 and 2 from the anisotropic elastic
network analysis (ANM), which shows direction of motion,
show striking similarities with the twisting and breathing
motions, respectively, observed in the MD simulations (Sup-
plementary Movies 1–4).
PCAanalysis of individual trajectories indicated that both
the breathing and twisting motions occurred in all simula-
tions. However, in comparing the apo and covalently ligand-
bound states, the breathing motions are greater in the apo
state while in the covalently ligand-bound state, the twisting
motions are greater. This is shown by the fluctuations along
EVs 2 and 3 for each trajectory (Supplementary Table 1).
Although the trend is weaker for the second set of simula-
tions, it is consistent both within trajectories and when com-
paring the apo and liganded states.Thus, the data suggest that
the extent of each motion may be determined by the ligand-
bound state.
3.6. Concerted Protein Dynamics and Ligand Release in the
Noncovalently Bound State. To investigate the protein-ligand
interaction, three simulations of the noncovalently ligand-
bound state were performed. The first of these was started
from the crystal structure, the second was started with
the C-terminal residues modeled as a continuous 𝛼-helix,
as described above, and the third started from the crystal
structure with ligand-binding residue Glu63 changed to the
wild-type glutamine. Significantly, in all three noncovalently
bound GSH simulations, the ligand was completely released
from the protein within 75 ns. In the ncv1 simulation, the
hydrogen bond between the ligand and the side chain
of Glu63, observed in the covalently bound simulations
remained unformed, as in the crystal structure, and the bond
between the ligand and the side chain of Asp76 was lost with-
in 4 ns; the ligand completely disengaged within 10 ns.
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In simulations ncv2 and ncv3, in which the ligand
remained bound for approximately 70 ns and 20 ns, respec-
tively, protein interactions with the ligand are the same as in
the two covalently bound simulations, with the exception of
the hydrogen bond between the backbone amide of the GSH
cystyl and the carbonyl oxygen of Leu64 (Supplementary Fig-
ure 6).This latter interaction remains stable throughout both
covalently ligand-bound simulations but forms only tran-
siently in simulations ncv2 and ncv3; in the covalently bound
state it appears to be stabilised by the covalent attachment of
the ligand cystyl moiety to the protein (Figure 5(a)).
From the fact that in both simulations ncv2 and ncv3 the
ligand had the opportunity to form the same complement of
interactions with the protein as observed in the covalently
attached ligand, we conclude that the disengagement of the
ligand was not due to artefacts relating to the formation of
required protein-ligand interactions, either during or follow-
ing the equilibration. In addition, we note that ligand release
occurred in all noncovalently bound simulations, regardless
of whether minimal counterions were employed as in ncv2 or
a 0.2M NaCl solution was used as in ncv1 and ncv3.
Visual inspection of the simulation trajectories suggested
that the mechanism of ligand release might involve dynamics
of the loop joining 𝛼-helix 2 and 𝛽-strand 3 (residues 59
to 65), which affects the interactions of residues Glu63 and
Leu64 with the ligand. Motions of this loop are allied to
high fluctuations of the 𝛼-helix 2 region (residues 50–60;
Figure 1(b)). PCA of the trajectories of the ncv2 and ncv3
simulations shows a peak for residues 60–63 in the per residue
plot of the most concerted 50% of C𝛼 atom fluctuations
(Figure 5(d)), indicating that motions of residues 60–63 are
part of concerted global dynamics of the protein.
Examination of the PCA of the ncv2 and ncv3 simulation
trajectories reveals that the fluctuations of residues 60–63 are
decomposed into a complex set of motions that alter their
position relative to the ligand and to other residues compris-
ing the ligand binding site. These motions would alter the
geometry of the ligand-binding site and in doing so, possibly
contribute to ligand release. In many instances, PCA modes
1–5 of the ncv2 and ncv3 trajectories involved alterations
in the backbone dihedral 𝜓 angle of ligand-binding residue
residue Glu/Gln63, and ligand release was approximately
coincident with sustained changes in this angle in both the
ncv2 and ncv3 simulations (Supplementary Figures 7(a) and
7(b)).
We performedPCAof the combined ncv2 andncv3 simu-
lation trajectories, not including frames following the onset of
ligand release (𝑡 = 67 ns and 𝑡 = 19.85 ns for ncv2 and ncv3,
resp.). EV4 from this analysis, which accounted for more
than 10% of all C𝛼 atom fluctuations, included alterations
in the backbone dihedral 𝜓 angle of ligand-binding residue
Glu/Gln63.Thismode also showed 12.7% and 52.3% subspace
overlap with EVs 2 and 3, respectively, from the PCA of the
combined apo1 and cov1 simulations (see above), which both
include significant motions of residues 60–63 (Figures 5(b)
and 5(c)). The projection of EV4 from PCA of the combined
ncv2 and ncv3 simulation trajectories on the complete ncv2
and ncv3 simulation trajectories revealed that ligand release
was coincident with themaximumprojection(s) in both cases
(Supplementary Figures 6(c) and 6(d)). Thus, a significant
global concerted motion that was detected prior to ligand
release reached its fullest extent coincident with ligand
release, in both the ncv2 and ncv3 simulations.
3.7. The Foot Loop is Conformationally and Dynamically
Variable. Analysis of the simulation trajectories shows that
the foot loop (residues 147–164) undergoes the highest fluc-
tuations within the protein (Figures 1(b) and 6(a)), consistent
with the disordered nature of this region in the crystal struc-
ture.The foot loopwas observed to be highlymobile and con-
formationally variable. This is depicted in Figure 6(b), which
shows the C𝛼 trace at regular intervals over the course of the
apo and covalently bound simulations. In simulations apo1
and cov2, the foot loop equilibrates to a generally more com-
pact conformation than in simulations apo2 and cov1; in the
latter simulations, it adopts a more extended andmobile con-
formation. The compact conformations observed in simula-
tions apo1 and cov2 are not similar in terms of their secondary
structure (Supplementary Figure 8), and although the lower
mobility of this region in simulations apo1 and cov2 appears,
at least in part, to be due to electrostatic interactions with the
residues within the structural core of the protein, these inter-
actions are not the same in the two simulations.The foot loop
is notable also for the high negative electrostatic potential sur-
rounding it (Figure 6(c)) and that it contains regions of high
sequence variability among CLICs (Supplementary Figure 9).
4. Discussion
In order to investigate the role and molecular mechanism of
CLIC1, we performed MD simulations of the three possible
ligand-bound states of the molecule, using the crystal struc-
ture of GSH-bound human CLIC1 as the starting structure.
For comparison with the results of the atomistic simulations,
elastic network analysis of the CLIC1 structure was also
performed. Two >100 ns MD simulations of the nonliganded
state revealed significant alterations of the protein around
and within the active site that resulted in direct interaction
between conserved residue Tyr233, situated within the C-
terminal helix 9, and the active site Cys24 thiol.These changes
involved characteristic alterations in the orientation of the
C-terminal 𝛼-helix and its extension at its C-terminus, and
concomitant changes in 𝛼-helix 6 and the downstream loop
encompassing residues 195–198. In two equivalent >100 ns
simulations of the covalently glutathione-bound state, move-
ment of Tyr233 toward Cys24 did not occur, nor did the other
changes described in the apo simulation; this was also true
when the C-terminal residues were modeled in an 𝛼-helical
conformation in the starting structure. PCA of the combined
trajectories of all simulations showed that the global change
that occurred in the apo1 simulationwas the largest amplitude
concerted motion that occurred in all simulations. Moreover,
elastic network analysis of the protein structure indicated that
the conformational changes observed in the apo simulations
involve motions intrinsic to the gross architecture and are
thus likely to be functional.
Since the structures of both ligand-bound (1KON) and
apo (1KOM) human CLIC1 are essentially identical (RMSD





















Figure 6: Structure and dynamics of the foot loop. (a) Fluctuations of the foot loop. Per residue fluctuations of C𝛼 atoms during the
simulations: apo1, red; apo2, blue; cov1, green; cov2, yellow; ncv2, purple. Fluctuations taken over the final 20 ns of each simulation relative to
the average structure over the same period for the respective simulation. (b) Conformational variability of the foot loop. Superimposed
trajectory frames taken at 7.5 ns intervals, coloured according to the time: start (blue); end (red). (c) Electronegativity of the foot loop.
Electrostatic potential around the structure of CLIC1 is depicted as a surface representing isovalues; potential of +1 is coloured blue and
−1 red. The view is similar to that in Figure 1. Final frame from each simulation was analysed.
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0.5 A˚; 6), the crystallographic analysis indicates that the
starting structure used in the simulations is the lowest free
energy conformation for both states. This appears to conflict
with the findings of the simulations, in which the unliganded
protein equilibrates to a distinct conformation. Nevertheless,
crystallographic analysis provides evidence that the altered
structure observed in the C-terminal residues in the equili-
brated apo1 simulation, which appears to be part of the overall
conformational change, could represent a physiological state.
Several CLIC protein crystal structures indicate that the
C-terminal region after helix 9 is less ordered than the
remainder of the protein. The C-terminal region (234–241)
was unresolved in a structure of oxidised CLIC1 (1RK4 [46]),
whereas in two structures of humanCLIC3 (3FY7, 3KJY [47]),
the conserved C-terminal tyrosine (equivalent to Tyr233 in
CLIC1) is the penultimate resolved residue, with the C-
terminal tail lacking ordered structure. In addition, in three
structures of human CLIC2A, temperature factors increase
for residues following 𝛼-helix 9 and for CLIC4; some struc-
tures also show increased B-factors after helix 9. These data
are consistent with the existence of alternative conformations
for the C-terminal residues.
Additionally, recent EPR experiments show that the
CLIC1C-terminal region switches from an ordered to a disor-
dered state when the protein interacts with lipid membranes
[48]. In these experiments, a spin label has been attached to
the conserved Cys223 between helices 8 and 9 in the oxidised
CLIC1 dimer state. In this state, the spin label shows low
mobility, consistent with a structured region of the protein.
On the addition of liposomes, the spin label becomes com-
pletely mobile. In the apo1 simulation, changes in the region
between helices 8 and 9 are important to the reorientation
of the C-terminal helix 9, and fluctuations in this region are
significantly lower in the cov1 simulation (Figure 6(b)).Thus,
the EPR data support the observed altered mobility of this
region observed between different states in the simulations
and the possibility that alterations in the orientation of the
C-terminal helix 9 occur and may have a physiological role.
The results of simulations may be interpreted as indicat-
ing that physiologically, the structure observed in the crystal
is in equilibrium with an alternative state, where the C-
terminal 𝛼-helix forms to the very terminus. If this forms
when Cys24 is covalently bound to glutathione, then there is
nothing to stabilise the extended helix state. However, in an
apo structure, Tyr233 can hydrogen bond to Cys24 and hence
add stability to the extended helix form.
What pins down the C-terminal extended structure in the
CLIC proteins? In CLIC1, 4, 5 and 6, two conserved non-
polar residues, Ala237 and Leu240 (Met in CLIC6), sit in
hydrophobic pockets formed by helices 4, 5, 6, and 9. In
CLIC2, Leu240 is replaced by Gln245, which packs in the
same pocket, which is now polar, with side chain hydrogen
bonds to Asn132. These structures are not present in CLIC3
and the extended C-terminal structure beyond the conserved
tyrosine in helix 9 is not observed.
The release of the extended C-terminal structure in the
CLIC1 MD simulations is correlated with structural changes
in the hydrophobic pockets to which Leu240 and Ala237
bind. Concomitant to the release of the C-terminus, signif-
icant changes are observed in the loop joining helix 6 to
helix 7 (residues 195–198), which forms part of the pockets.
This region directly follows the putative nuclear localization
sequence Lys192-Lys193-Tyr194-Arg195, which needs to adopt
a linear conformation in order to bind importin 𝛼 for nuclear
transport [49]. Thus, the structural changes that result in the
release of theC-terminal extended regionmay be prerequisite
for the exposure of the putative nuclear localization sequence
and hence nuclear transport of the CLIC protein.
Calculation of the pKa of the active site cysteine thiol
indicated that is less reactive in the conformation in the
>100 ns equilibrated apo structure than in the conforma-
tion observed in the starting structure. Thus, the proximity
between Tyr233 and Cys24, observed in the apo simulations,
appears to induce and/or stabilise a less reactive conformer of
the active site thiol. Residue Tyr233 is conserved in all verte-
brate CLIC sequences to date. Its ability to contact the active
site cysteine in a ligand-dependent manner, as indicated by
the simulations, suggests that it may have a catalytic role,
possibly in breaking and/or formation of the covalent bond
between Cys24 and the GSH ligand, and/or the transfer of
GSH to or from another molecule. The possible importance
of Tyr233 in reactions of the active site is also supported by the
NetPhos neural network analysis, which suggests that it may
be a tyrosine kinase phosphorylation site. The less reactive
conformation of the active site cysteine, together with the
observation that the side chain of Phe26 transiently occupies
the ligand-binding space in the apo simulations, suggests that
the probability of spontaneous ligand binding is reduced in
the unliganded state.
The simulation results indicate that interactions of GSH
with the protein in the covalently bound state are similar
to those observed in GSTs. Notwithstanding the existence
of an intact glutaredoxin-like GSH binding site, in three
simulations of the noncovalently bound state, the ligand is
rapidly released from the protein. This appears to occur by a
mechanism involving concerted global dynamics. The rapid
release of GSH in all three noncovalently ligand-bound sim-
ulations is consistent with experimental data which showed
that non-covalent binding of GSH to CLIC1 is weak (𝑘
𝑑
>
10mM; 6) compared to that observed in GSTs, which show
strongGSHbinding (𝑘
𝑑
∼𝜇M[50]). Together, the data suggest
that, when the ligand is absent or present but not covalently
bound, CLIC1 is in a state conformationally and dynamically
that is not conducive to spontaneous covalent binding ofGSH
to the ligand binding site.
PCA analysis of the simulation trajectories detects and
distinguishes two different kinds of motions between the
N- and C-terminal subdomains. In the nonliganded state,
an opening and closing of the gap around the active site
formed by these subdomains are the predominant motion,
whereas in covalently ligand bound state, a twisting motion
with respect to these subdomains along the long axis of
the protein is the predominant motion. Significantly, EN
analysis modes 1 and 2 show remarkable similarities with
the twisting and breathing motions between the N- and C-
terminal subdomains, respectively, indicating that they are
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fundamental to the architecture of CLIC1 and are thus likely
to be of functional significance.
Since GSH is unlikely to bind covalently to CLIC spon-
taneously under physiological conditions, the conclusion fol-
lows that covalent binding of GSH to CLIC requires interac-
tion with another protein. Such an interaction could alter the
structure and/or dynamics of CLIC to increase the binding
affinity for GSH and/or to transfer the ligand. The region
of the mouth around the active site and the associated cleft
between the N- and C-terminal domains, which undergoes
the greatest changes in the simulations, is expected to be the
site of docking of other molecules. Thus, it seems reasonable
to suggest that the breathing motion in the unliganded state
could aid the binding of a glutathione transferase, while the
twisting motion in the covalently ligand-bound state would
induce its release.
The simulations also show that the foot loop region of
the protein (residues 147–164) is able to adopt both extended,
highly mobile conformations, as well as more compact, less
dynamic conformations.The high conformational variability
of the foot loop appears similar to that described for intrin-
sically disordered or unstructured regions of other proteins.
In many cases, natively unstructured regions are involved
in recognition and binding to other proteins or macro-
molecules; a relatively unstructured region can have a greater
capture radius for a specific binding site than the folded state
with its restricted conformational freedom [51]. Unstructured
regions also have the potential to bind multiple targets.
Indeed, the behaviour of the foot loop in simulations apo2
and cov1 resembles broadly the description of the process
of recognition and binding of unstructured regions to their
targets as a “fly casting”mechanism [52].Thehigh electroneg-
ativity of the foot loop (Figure 6(c)) could aid in the weak
longer-range nonspecific binding, proposed to be the initial
phase of the fly casting binding process [52]. In this context,
it is interesting that the secondary structure that forms in the
foot loop is more fragmented temporally in the simulations
with 0.2M NaCl than in the second set of simulations with
minimal counterions (Supplementary Figure 8).This suggests
the possibility that external electrostatic interactions may
influence the structure of the region. Since the foot loop
contains regions of high sequence variability among CLICs
(Supplementary Figure 8), it seems possible that it may be
part of a recognition interface with other proteins. However,
since the behaviour of the foot loop appears uncorrelatedwith
the ligand-bound state, what role this might play is uncertain.
The data do not appear to shed any light on the way
in which CLIC might undergo a radical conformational
change and form a transmembrane chloride channel, with
the rms deviation of the C𝛼 atoms remaining <3 A˚ for each
simulation. This may be due to the limited length of the
simulations. Alternatively, CLIC1 may require interaction
with another protein and/or the membrane to refold and
insert into the membrane.
Abbreviations
CLIC: Chloride intracellular channel
MD: Molecular dynamics
RMS: Root mean square
PCA: Principal component analysis
EV: Eigenvector.
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